Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Vallvé JC, Ferré R, Heras M, Rodríguez-Calvo R, Guaita-Esteruelas S, Martínez-Micaelo N, Plana N, Masana L.

J Clin Med. 2019 Oct 26;8(11). pii: E1793. doi: 10.3390/jcm8111793.

2.

Update of therapeutic planning tables oriented towards obtaining therapeutic objectives.

Masana L, Plana N.

Clin Investig Arterioscler. 2019 Nov - Dec;31(6):271-277. doi: 10.1016/j.arteri.2019.04.005. Epub 2019 Jul 9. English, Spanish.

PMID:
31296342
3.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.

4.

Plasma glucose, triglycerides, VLDL, leptin and resistin levels as potential biomarkers for myocardial fat in mice.

Rodríguez-Calvo R, Samino S, Guaita-Esteruelas S, Martínez-Micaelo N, Heras M, Girona J, Yanes O, Correig X, Masana L.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30064-6. doi: 10.1016/j.arteri.2019.05.001. [Epub ahead of print] English, Spanish.

PMID:
31221535
5.

MicroRNA differential expression shared between rheumatoid arthritis and acute myocardial infarction: an exploratory study.

Paredes S, Taverner D, Ferré R, Alegret JM, Masana L, Vallvé JC.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):886-887. Epub 2019 Jun 3. No abstract available.

6.

Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.

Rodríguez-Calvo R, Girona J, Rodríguez M, Samino S, Barroso E, de Gonzalo-Calvo D, Guaita-Esteruelas S, Heras M, van der Meer RW, Lamb HJ, Yanes O, Correig X, Llorente-Cortés V, Vázquez-Carrera M, Masana L.

Metabolism. 2019 Jul;96:12-21. doi: 10.1016/j.metabol.2019.04.007. Epub 2019 Apr 15.

PMID:
30999003
7.

Assessment of arterial stiffness variables in patients with rheumatoid arthritis: A mediation analysis.

Taverner D, Paredes S, Ferré R, Masana L, Castro A, Vallvé JC.

Sci Rep. 2019 Mar 14;9(1):4543. doi: 10.1038/s41598-019-41069-5.

8.

Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway.

Girona J, Rosales R, Saavedra P, Masana L, Vallvé JC.

Am J Physiol Cell Physiol. 2019 Jun 1;316(6):C888-C897. doi: 10.1152/ajpcell.00293.2018. Epub 2019 Mar 13.

PMID:
30865473
9.

Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.

Rodríguez M, Guardiola M, Oliva I, Carles Vallvé J, Ferré R, Masana L, Parra S, Ribalta J, Castro A.

Int J Rheum Dis. 2019 Mar;22(3):480-487. doi: 10.1111/1756-185X.13445. Epub 2018 Nov 18.

PMID:
30450745
10.

Characterization of 1H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid Arthritis.

Fuertes-Martín R, Taverner D, Vallvé JC, Paredes S, Masana L, Correig Blanchar X, Amigó Grau N.

J Proteome Res. 2018 Nov 2;17(11):3730-3739. doi: 10.1021/acs.jproteome.8b00411. Epub 2018 Oct 24.

PMID:
30353728
11.

Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.

Ibarretxe D, Rodríguez-Borjabad C, Feliu A, Bilbao JÁ, Masana L, Plana N.

Atherosclerosis. 2018 Nov;278:210-216. doi: 10.1016/j.atherosclerosis.2018.09.039. Epub 2018 Oct 1.

PMID:
30312929
12.

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.

Bosquet A, Girona J, Guaita-Esteruelas S, Heras M, Saavedra-García P, Martínez-Micaelo N, Masana L, Rodríguez-Calvo R.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jun;1863(6):604-613. doi: 10.1016/j.bbalip.2018.03.004. Epub 2018 Mar 15.

PMID:
29550588
13.

Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.

Taverner D, Vallvé JC, Ferré R, Paredes S, Masana L, Castro A.

PLoS One. 2018 Mar 1;13(3):e0193690. doi: 10.1371/journal.pone.0193690. eCollection 2018.

14.

Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study.

Morales C, Plana N, Arnau A, Matas L, Mauri M, Vila À, Vila L, Soler C, Montesinos J, Masana L, Pedro-Botet J; en nombre del grupo de Investigadores EROMOT-XULA.

Clin Investig Arterioscler. 2018 Jan - Feb;30(1):1-9. doi: 10.1016/j.arteri.2017.07.003. Epub 2017 Sep 12. English, Spanish.

PMID:
28916128
15.

Is there a role for lifestyle changes in cardiovascular prevention? What, when and how?

Masana L, Ros E, Sudano I, Angoulvant D; lifestyle expert working group.

Atheroscler Suppl. 2017 Apr;26:2-15. doi: 10.1016/S1567-5688(17)30020-X. Review.

PMID:
28434481
16.

Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.

Rodríguez-Calvo R, Girona J, Alegret JM, Bosquet A, Ibarretxe D, Masana L.

J Endocrinol. 2017 Jun;233(3):R173-R184. doi: 10.1530/JOE-17-0031. Epub 2017 Apr 18. Review.

PMID:
28420707
17.

Familial hypercholesterolemia in childhood and adolescents: A hidden reality.

Plana N, Rodríguez-Borjabad C, Ibarretxe D, Masana L.

Clin Investig Arterioscler. 2017 May - Jun;29(3):129-140. doi: 10.1016/j.arteri.2016.11.002. Epub 2017 Apr 5. English, Spanish.

PMID:
28390853
18.

Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.

Villa G, Lothgren M, Kutikova L, Lindgren P, Gandra SR, Fonarow GC, Sorio F, Masana L, Bayes-Genis A, Hout BV.

Clin Ther. 2017 Apr;39(4):771-786.e3. doi: 10.1016/j.clinthera.2017.02.011. Epub 2017 Mar 31.

PMID:
28366593
19.

Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.

Merino J, Leong A, Posner DC, Porneala B, Masana L, Dupuis J, Florez JC.

Diabetes Care. 2017 May;40(5):687-693. doi: 10.2337/dc16-2625. Epub 2017 Mar 15.

20.

APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.

Oliva I, Guardiola M, Vallvé JC, Ibarretxe D, Plana N, Masana L, Monk D, Ribalta J.

Clin Sci (Lond). 2016 Nov 1;130(22):2053-2059. doi: 10.1042/CS20160433. Epub 2016 Sep 9.

PMID:
27613158

Supplemental Content

Loading ...
Support Center